Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Kowa Pharmaceuticals America (Diclofenac Products)

M&A STATUS
Asset Purch. LATEST DEAL TYPE
2 FINANCING ROUNDS
Description

Portfolio of diclofenac products. The portfolio comprises of Cambia a diclofenac potassium for oral consumption used for the treatment of acute migraine headache pain.

Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Pharmaceuticals
Primary Office
  • United States

Kowa Pharmaceuticals America (Diclofenac Products) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Kowa Pharmaceuticals America (Diclofenac Products)‘s full profile, request access.

Request full access to PitchBook

Kowa Pharmaceuticals America (Diclofenac Products) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Kowa Pharmaceuticals America (Diclofenac Products)‘s full profile, request access.

Request full access to PitchBook